Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

SUPN Supernus Pharmaceuticals PE ratio, current and historical analysis

The current P/E ratio for Supernus Pharmaceuticals stock as of Jun 4, 2025 is 28.58. This is calculated based on the TTM EPS of $1.13 and the stock price of $32.3 per share. The PE ratio has decreased by 70% from its last 4 quarters average of 95.5.

SUPN PE ratio history

How has SUPN's PE ratio performed in the past

The average historical PE ratio of Supernus Pharmaceuticals for the last ten years is 73.41. The current price-to-earnings ratio of 28.58 is 61% less than the historical average. Analyzing the last ten years, SUPN's PE ratio reached its highest point in the Dec 2023 quarter at 1,447, when the price was $28.94 and the EPS was $0.02. The lowest point was recorded in the Mar 2020 quarter, when it reached 8.14 with a price of $17.99 and an EPS of $2.21.

Today
28.58
Average
73.41
Median
26.99
Minimum
8.14
Maximum
1,447

Supernus Pharmaceuticals PE ratio by year

Maximum annual increase: 4,483.47% in 2023

Maximum annual decrease: -98.13% in 2024

Year PE ratio PE change Price EPS
2024 26.99 -98.13% $36.16 $1.34
2023 1,447 4,483.47% $28.94 $0.02
2022 31.57 9.35% $35.67 $1.13
2021 28.87 176.53% $29.16 $1.01
2020 10.44 -4.92% $25.16 $2.41
2019 10.98 -29.62% $23.72 $2.16
2018 15.6 -55.77% $33.22 $2.13
2017 35.27 157.07% $39.85 $1.13
2016 13.72 -70.39% $25.25 $1.84
2015 46.34 N/A $13.44 $0.29
2014 N/A N/A $8.3 -$0.26
2013 N/A N/A $7.54 -$2.9
2012 N/A N/A $7.17 -$2.72
2011 N/A N/A N/A $31.39
2010 N/A N/A N/A -$26.38

Supernus Pharmaceuticals PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Mar 2025 28.98 7.37% $32.75 $1.13
Dec 2024 26.99 -6.51% $36.16 $1.34
Sep 2024 28.87 -90.29% $31.18 $1.08
Jun 2024 297.22 N/A $26.75 $0.09
Mar 2024 N/A N/A $34.11 -$0.29
Dec 2023 1,447 2,366.76% $28.94 $0.02
Sep 2023 58.66 54.17% $27.57 $0.47
Jun 2023 38.05 0.82% $30.06 $0.79
Mar 2023 37.74 19.54% $36.23 $0.96
Dec 2022 31.57 -33.79% $35.67 $1.13
Sep 2022 47.68 79.72% $33.85 $0.71
Jun 2022 26.53 14.11% $28.92 $1.09
Mar 2022 23.25 -19.47% $32.32 $1.39
Dec 2021 28.87 67.75% $29.16 $1.01
Sep 2021 17.21 6.17% $26.67 $1.55

SUPN Price vs fair value

How does SUPN's price compare to its estimated fair value based on its growth

SUPN average PE ratio chart

What is the average PE ratio of SUPN for the past years

The current PE ratio of SUPN is under its 3, 5 and 10-year averages.

3-year avg
188.12
5-year avg
115.62
10-year avg
73.41
15-year avg
N/A

SUPN PE vs peers

What is SUPN's PE ratio compared to its peers

SUPN's PE ratio is less than its peer stock LLY, but it is above JNJ's and ABT's. Supernus Pharmaceuticals is currently trading at a higher PE ratio (28.58) than its peers average of 25.21.

Stock name PE ratio Market cap
UTHR UNITED THERAPEUTICS Corp 11.96 $14.61B
JNJ Johnson & Johnson 16.91 $368.66B
ABT Abbott Laboratories 17.22 $231.33B
BMY Bristol Myers Squibb Co 17.89 $97.58B
SUPN Supernus Pharmaceuticals Inc 28.58 $1.81B
LLY ELI LILLY & Co 62.06 $725.81B

Frequently asked questions

What is Supernus Pharmaceuticals's PE ratio?

The price to earnings ratio for SUPN stock as of Jun 4, 2025, stands at 28.58.

What is the 3-year average PE ratio for Supernus Pharmaceuticals (SUPN)?

Over the last 3 years, the average PE ratio for SUPN stock is 188.12.

What is the 5-year average PE ratio for Supernus Pharmaceuticals (SUPN)?

Over the last 5 years, the average PE ratio for SUPN stock is 115.62.

What is the highest PE ratio for SUPN?

The highest quarterly PE ratio in the last ten years has been 1,447 and it was in the Dec 2023 quarter.

How does the current PE ratio for SUPN compare to its historical average?

The current PE ratio of SUPN is 61% lower than the 10-year historical average.

How is SUPN's PE ratio calculated (Supernus Pharmaceuticals PE ratio formula)?

The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Jun 4, 2025), Supernus Pharmaceuticals's share price is $32.3. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $1.13. Therefore, Supernus Pharmaceuticals's price to earnings ratio for today is 28.58. PE RATIO(28.58) = STOCK PRICE($32.3) / TTM EPS($1.13)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.